Nebenwirkungen · Gobivaz
GOBIVAZ 50 mg solution for injection in pre-filled syringe. · Abschnitt 4.8 · PDF-Seite 12–13
HOS-153473 · Präparat HOS-101000
12 Respiratory, thoracic and mediastinal disorders Common: Asthma and related symptoms (such as wheezing and bronchial hyperactivity) Uncommon: Interstitial lung disease Gastrointestinal disorders Common: Dyspepsia, gastrointestinal and abdominal pain, nausea, gastrointestinal inflammatory disorders (such as gastritis and colitis), stomatitis Uncommon: Constipation, gastro-oesophageal reflux disease Hepatobiliary disorders Common: Alanine aminotransferase increased, aspartate aminotransferase increased Uncommon: Cholelithiasis, hepatic disorders Skin and subcutaneous tissue disorders Common: Pruritus, rash, alopecia, dermatitis Uncommon: Bullous skin reactions, psoriasis (new onset or worsening of pre-existing psoriasis, palmar/plantar and pustular), urticaria Rare: Lichenoid reactions, skin exfoliation, vasculitis (cutaneous) Not known: Worsening of symptoms of dermatomyositis Musculoskeletal and connective tissue disorders Rare: Lupus-like syndrome
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-07-21T10:38:00Z · SHA-256 b368a4f3ae6dce5887430617ccfcdc36900996af800ff08514415b29e19f2102 · Passage 52c11c31d889bdb789af437a1e96daf163cb754e0c91936812012af2d1872f95 · Zeichen 4771–6279 im Abschnitt